Fact CheckerSign in

NCT06330818Recruiting

Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients

IMAGINE - Imaging in Moyamoya Disease

Source: ClinicalTrials.gov · Last updated 26 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Aim of this study is to improve patient care in Moyamoya Patients by improving Imaging technologies and aiming to identify factors involved in disease progression. Main tasks are: * Analysis of CO2-triggered BOLD fMRI for analysis of cerebral hemodynamics in comparison to H2 15O PET/CT * Analysis of longitudinal changes of contrast enhancement in vessel-wall imaging and correlation of disease activity with biosampling * Definition of a standardized recommendation for pre- and postoperative imaging of Moyamoya patients

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
12 Mar 2024
Start date
1 Jul 2024
Primary completion date
30 Jul 2027
Lead sponsor
University Hospital Tuebingen
Diseases
Stroke
NCT number
NCT06330818

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 1 Jul 2024 to the primary completion date, 30 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cerebral vascular disease caused by atherosclerosis
  • Renal insufficiency

Other

  • Vasculitis
  • Contraindications to MRI
  • Contraindications to PET/CT
  • Pregnancy
  • Inability to give informed consent

Who the study is looking for

  • Patients with suspicion of Moyamoya Disease
  • Patients able to understand the study and to give their informed consent

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Tuebingen, Neurosurgery
Coordinator of this site? Confirm its status
TübingenGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.